rowid,run.accession,experiment.accession,sample.accession,study.accession,bioproject,study.title,study.alias,study.type,study.abstract,study.attributes,study.PMIDs,sample.description,sample.title,sample.alias,sample.centername,sample.attributes,GEOsample.title,GEOsample.dataprocessing,GEOsample.source,GEOsample.treatmentprotocol,GEOsample.extractprotocol,GEOsample.growthprotocol,GEOsample.characteristics,GEOsample.accession,experiment.title,experiment.alias,experiment.library_name,experiment.design_description,experiment.library_construction_protocol,experiment.attributes,experiment.library_strategy,experiment.library_source,experiment.library_selection,experiment.library_layout,experiment.platform,experiment.instrument_model,experiment.spot_descriptor,experiment.study_ref,run.title,run.attributes,run.filename,run.semantic_name,run.total_bases,run.total_spots,run.alias,run.read_lengths,run.base_counts,run.r1_length,run.r2_length,run.r3_length,run.r4_length,run.Acount,run.Ccount,run.Gcount,run.Tcount,run.Ncount,run.experiment,run.pool_member,submission.accession,submission.srasource,submission.bioprojectsource,seqdetective.n_mates,seqdetective.mapping_rate.mate1,seqdetective.mapping_rate.mate2,seqdetective.nofeature_rate.mate1,seqdetective.nofeature_rate.mate2,seqdetective.sparsity.mate1,seqdetective.sparsity.mate2,seqdetective.pos_strand_rate.mate1,seqdetective.pos_strand_rate.mate2,seqdetective.readlen.mate1,seqdetective.readlen.mate2,seqdetective.judgement.mate1,seqdetective.judgement.mate2,seqdetective.judgement.reason,platform_family,instrument_generation,read_bias,selection_class,prep_kit,sc_or_bulk,tech_class,technology,tech_variant,submission.bioprojectsource.country,earliest_date,devstage_curation,devstage_curation_coarse,tissue_curation,tissue_curation_coarse 42495,SRR5666979,SRX2902577,SRS2269173,SRP108989,PRJNA390119,HLX & Hematopoiesis,PRJNA390119,Other,HLX & Hematopoiesis,,,rnaseq and atacseq,hlx hematopoiesis,hlx,,isolate:multiisolates|age:N/A|sex:pooled male and female|tissue:heart|BioSampleModel:Model organism or animal,,,,,,,,,kdrl GFP cells hlx1 MO rep2,3,kdrl GFP cells hlx1 MO rep2,SMART SEQ ultra low RNA seq kit Clonetech,,,RNA-Seq,TRANSCRIPTOMIC,size fractionation,PAIRED,ILLUMINA,Illumina HiSeq 2500,1500Application ReadForward11Application ReadReverse76,SRP108989,,assembly:danRer10,flk_gfp_hlx_8ng_48hrs_2_R1.fastq.gz flk_gfp_hlx_8ng_48hrs_2_R2.fastq.gz,fastq fastq,1887289200.0,12581928.0,flk gfp hlx 8ng 48hrs 2 R1.fastq.gz,0:75 1:75,A:493825524;C:448630716;G:436118597;T:508410442;N:303921,75,75,,,493825524,448630716,436118597,508410442,303921,SRX2902577,SRS2269173,SRA573518,BRFAA|Molecular Biology,BRFAA,2,0.9202,0.9216,0.09499,0.09558,0.73805,0.73878,0.48809,0.48787,75,75,B,B,biological fallback assumption,illumina,hiseq_era,unknown,size_fractionation,unknown,bulk,unknown,unknown,,Greece,2017-06-13,Undetermined,Undetermined,Heart,Cardiovascular System 42496,SRR5666980,SRX2902576,SRS2269173,SRP108989,PRJNA390119,HLX & Hematopoiesis,PRJNA390119,Other,HLX & Hematopoiesis,,,rnaseq and atacseq,hlx hematopoiesis,hlx,,isolate:multiisolates|age:N/A|sex:pooled male and female|tissue:heart|BioSampleModel:Model organism or animal,,,,,,,,,kdrl GFP cells hlx1 MO rep1,2,kdrl GFP cells hlx1 MO rep1,SMART SEQ ultra low RNA seq kit Clonetech,,,RNA-Seq,TRANSCRIPTOMIC,size fractionation,PAIRED,ILLUMINA,Illumina HiSeq 2500,1500Application ReadForward11Application ReadReverse76,SRP108989,,assembly:danRer10,flk_gfp_hlx_8ng_48hrs_1_R1.fastq.gz flk_gfp_hlx_8ng_48hrs_1_R2.fastq.gz,fastq fastq,1561083900.0,10407226.0,flk gfp hlx 8ng 48hrs 1 R2.fastq.gz,0:75 1:75,A:412744284;C:366776465;G:356834742;T:424473871;N:254538,75,75,,,412744284,366776465,356834742,424473871,254538,SRX2902576,SRS2269173,SRA573518,BRFAA|Molecular Biology,BRFAA,2,0.9172,0.91824,0.09957,0.09961,0.73965,0.73975,0.48906,0.48977,75,75,B,B,biological fallback assumption,illumina,hiseq_era,unknown,size_fractionation,unknown,bulk,unknown,unknown,,Greece,2017-06-13,Undetermined,Undetermined,Heart,Cardiovascular System 42497,SRR5666981,SRX2902575,SRS2269173,SRP108989,PRJNA390119,HLX & Hematopoiesis,PRJNA390119,Other,HLX & Hematopoiesis,,,rnaseq and atacseq,hlx hematopoiesis,hlx,,isolate:multiisolates|age:N/A|sex:pooled male and female|tissue:heart|BioSampleModel:Model organism or animal,,,,,,,,,kdrl GFP cells control 2,1,kdrl GFP cells control 2,SMART SEQ ultra low RNA seq kit Clonetech,,,RNA-Seq,TRANSCRIPTOMIC,size fractionation,PAIRED,ILLUMINA,Illumina HiSeq 2500,1500Application ReadForward11Application ReadReverse76,SRP108989,,assembly:danRer10,flk_gfp_48hrs_con2_R1.fastq.gz flk_gfp_48hrs_con2_R2.fastq.gz,fastq fastq,2042164500.0,13614430.0,flk gfp 48hrs con2 R1.fastq.gz,0:75 1:75,A:537008617;C:483956616;G:465380092;T:555490621;N:328554,75,75,,,537008617,483956616,465380092,555490621,328554,SRX2902575,SRS2269173,SRA573518,BRFAA|Molecular Biology,BRFAA,2,0.91492,0.91762,0.10575,0.10669,0.75519,0.75546,0.49482,0.49617,75,75,B,B,biological fallback assumption,illumina,hiseq_era,unknown,size_fractionation,unknown,bulk,unknown,unknown,,Greece,2017-06-13,Undetermined,Undetermined,Heart,Cardiovascular System 42498,SRR5666982,SRX2902574,SRS2269173,SRP108989,PRJNA390119,HLX & Hematopoiesis,PRJNA390119,Other,HLX & Hematopoiesis,,,rnaseq and atacseq,hlx hematopoiesis,hlx,,isolate:multiisolates|age:N/A|sex:pooled male and female|tissue:heart|BioSampleModel:Model organism or animal,,,,,,,,,kdrl GFP cells control 1,0,kdrl GFP cells control 1,SMART SEQ ultra low RNA seq kit Clonetech,,,RNA-Seq,TRANSCRIPTOMIC,size fractionation,PAIRED,ILLUMINA,Illumina HiSeq 2500,1500Application ReadForward11Application ReadReverse76,SRP108989,,assembly:danRer10,flk_gfp_48hrs_con1_R2.fastq.gz flk_gfp_48hrs_con1_R1.fastq.gz,fastq fastq,1678987200.0,11193248.0,flk gfp 48hrs con1 R2.fastq.gz,0:75 1:75,A:437283407;C:401234553;G:387947515;T:452257282;N:264443,75,75,,,437283407,401234553,387947515,452257282,264443,SRX2902574,SRS2269173,SRA573518,BRFAA|Molecular Biology,BRFAA,2,0.91593,0.91737,0.08937,0.08988,0.75607,0.75696,0.50103,0.45539,75,75,B,B,biological fallback assumption,illumina,hiseq_era,unknown,size_fractionation,unknown,bulk,unknown,unknown,,Greece,2017-06-13,Undetermined,Undetermined,Heart,Cardiovascular System 42499,SRR5666985,SRX2902571,SRS2269173,SRP108989,PRJNA390119,HLX & Hematopoiesis,PRJNA390119,Other,HLX & Hematopoiesis,,,rnaseq and atacseq,hlx hematopoiesis,hlx,,isolate:multiisolates|age:N/A|sex:pooled male and female|tissue:heart|BioSampleModel:Model organism or animal,,,,,,,,,fli GFP cells hHLXOE rep 2,5,fli GFP cells hHLXOE rep 2,SMART SEQ ultra low RNA seq kit Clonetech,,,RNA-Seq,TRANSCRIPTOMIC,size fractionation,PAIRED,ILLUMINA,Illumina HiSeq 2500,1500Application ReadForward11Application ReadReverse76,SRP108989,,assembly:danRer10,fli_gal4_uas_hlx_endo_48h_s2_R2.fastq.gz fli_gal4_uas_hlx_endo_48h_s2_R1.fastq.gz,fastq fastq,4490898450.0,29939323.0,fli gal4 uas hlx endo 48h s2 R2.fastq.gz,0:75 1:75,A:870349076;C:1346136891;G:1401796534;T:869066463;N:3549486,75,75,,,870349076,1346136891,1401796534,869066463,3549486,SRX2902571,SRS2269173,SRA573518,BRFAA|Molecular Biology,BRFAA,2,0.5714,0.57344,0.27957,0.28321,0.85102,0.85342,0.53304,0.53368,75,75,B,B,biological fallback assumption,illumina,hiseq_era,unknown,size_fractionation,unknown,bulk,unknown,unknown,,Greece,2017-06-13,Undetermined,Undetermined,Heart,Cardiovascular System 42500,SRR5666986,SRX2902570,SRS2269173,SRP108989,PRJNA390119,HLX & Hematopoiesis,PRJNA390119,Other,HLX & Hematopoiesis,,,rnaseq and atacseq,hlx hematopoiesis,hlx,,isolate:multiisolates|age:N/A|sex:pooled male and female|tissue:heart|BioSampleModel:Model organism or animal,,,,,,,,,fli GFP cells hHLXOE rep 1,4,fli GFP cells hHLXOE rep 1,SMART SEQ ultra low RNA seq kit Clonetech,,,RNA-Seq,TRANSCRIPTOMIC,size fractionation,PAIRED,ILLUMINA,Illumina HiSeq 2500,1500Application ReadForward11Application ReadReverse76,SRP108989,,assembly:danRer10,fli_gal4_uas_hlx_endo_48h_s1_R1.fastq.gz fli_gal4_uas_hlx_endo_48h_s1_R2.fastq.gz,fastq fastq,3459602100.0,23064014.0,fli gal4 uas hlx endo 48h s1 R1.fastq.gz,0:75 1:75,A:658343595;C:1050309687;G:1097759573;T:650443491;N:2745754,75,75,,,658343595,1050309687,1097759573,650443491,2745754,SRX2902570,SRS2269173,SRA573518,BRFAA|Molecular Biology,BRFAA,2,0.57077,0.57481,0.2173,0.2185,0.79553,0.79762,0.50405,0.48708,75,75,B,B,biological fallback assumption,illumina,hiseq_era,unknown,size_fractionation,unknown,bulk,unknown,unknown,,Greece,2017-06-13,Undetermined,Undetermined,Heart,Cardiovascular System 55379,SRR10323881,SRX7034716,SRS5554730,SRP226614,PRJNA578896,Repetitive elements engage Rig I and Mda5 in interplay with Lgp2 to enhance hematopoietic stem cell emergence,PRJNA578896,Other,In this study we examine the role of RIG I like receptors RLRs in hematopoietic stem and progenitor cell formation. We have performed extensive expression analysis and chromatin accessibility assays on endothelial and hemogenic endothelial cells in knockdown animals for all the RLR receptors. Additionally we did expression analysis on animals with knockdown of two receptors. Finally we examined the upregulation of repetitive elements in hemogenic endothelial cells post treatment with valproic acid VPA or decitabine.,,,,,danRer10 raw data,,strain:AB/tu|age:not applicable|sex:pooled male and female|tissue:endothelial and hemogenic endothelial|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq control for lgp2 morpholino injected endothelial hemogenic endothelial cell 26hpf replicate 2,10,10,NEBNext Low Input RNA Library Prep Kit,,,RNA-Seq,TRANSCRIPTOMIC,size fractionation,PAIRED,ILLUMINA,Illumina HiSeq 3000,,SRP226614,,,RNA_seq control for lgp2 morpholino injected endothelial_hemogenic endothelial cell 26hpf replicate 2_R1.fastq.gz RNA_seq control for lgp2 morpholino injected endothelial_hemogenic endothelial cell 26hpf replicate 2_R2.fastq.gz,fastq fastq,3356658750.0,22377725.0,RNA seq control for lgp2 morpholino injected endothelial hemogenic endothelial cell 26hpf replicate 2 R1.fastq.gz,0:75 1:75,A:875300673;C:782517555;G:796855605;T:901672776;N:312141,75,75,,,875300673,782517555,796855605,901672776,312141,SRX7034716,SRS5554730,SRA983011,"Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany|Department of Cellular and Molecular Immunology","Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany",2,0.68437,0.73326,0.04743,0.05194,0.80241,0.80517,0.51875,0.52196,75,75,B,B,biological fallback assumption,illumina,hiseq_era,unknown,size_fractionation,nebnext,bulk,unknown,unknown,,Germany,2019-10-24,Pharyngula,Embryo,Endothelium,Cardiovascular System 55380,SRR10323882,SRX7034715,SRS5554730,SRP226614,PRJNA578896,Repetitive elements engage Rig I and Mda5 in interplay with Lgp2 to enhance hematopoietic stem cell emergence,PRJNA578896,Other,In this study we examine the role of RIG I like receptors RLRs in hematopoietic stem and progenitor cell formation. We have performed extensive expression analysis and chromatin accessibility assays on endothelial and hemogenic endothelial cells in knockdown animals for all the RLR receptors. Additionally we did expression analysis on animals with knockdown of two receptors. Finally we examined the upregulation of repetitive elements in hemogenic endothelial cells post treatment with valproic acid VPA or decitabine.,,,,,danRer10 raw data,,strain:AB/tu|age:not applicable|sex:pooled male and female|tissue:endothelial and hemogenic endothelial|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq control for lgp2 morpholino injected endothelial hemogenic endothelial cell 26hpf replicate 1,9,9,NEBNext Low Input RNA Library Prep Kit,,,RNA-Seq,TRANSCRIPTOMIC,size fractionation,PAIRED,ILLUMINA,Illumina HiSeq 3000,,SRP226614,,,RNA_seq control for lgp2 morpholino injected endothelial_hemogenic endothelial cell 26hpf replicate 1_R2.fastq.gz RNA_seq control for lgp2 morpholino injected endothelial_hemogenic endothelial cell 26hpf replicate 1_R1.fastq.gz,fastq fastq,3459242400.0,23061616.0,RNA seq control for lgp2 morpholino injected endothelial hemogenic endothelial cell 26hpf replicate 1 R1.fastq.gz,0:75 1:75,A:924400584;C:762078140;G:779330250;T:993109509;N:323917,75,75,,,924400584,762078140,779330250,993109509,323917,SRX7034715,SRS5554730,SRA983011,"Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany|Department of Cellular and Molecular Immunology","Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany",2,0.67032,0.73764,0.07629,0.08303,0.80856,0.80748,0.52094,0.52695,75,75,B,B,biological fallback assumption,illumina,hiseq_era,unknown,size_fractionation,nebnext,bulk,unknown,unknown,,Germany,2019-10-24,Pharyngula,Embryo,Endothelium,Cardiovascular System 55381,SRR10323883,SRX7034714,SRS5554730,SRP226614,PRJNA578896,Repetitive elements engage Rig I and Mda5 in interplay with Lgp2 to enhance hematopoietic stem cell emergence,PRJNA578896,Other,In this study we examine the role of RIG I like receptors RLRs in hematopoietic stem and progenitor cell formation. We have performed extensive expression analysis and chromatin accessibility assays on endothelial and hemogenic endothelial cells in knockdown animals for all the RLR receptors. Additionally we did expression analysis on animals with knockdown of two receptors. Finally we examined the upregulation of repetitive elements in hemogenic endothelial cells post treatment with valproic acid VPA or decitabine.,,,,,danRer10 raw data,,strain:AB/tu|age:not applicable|sex:pooled male and female|tissue:endothelial and hemogenic endothelial|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq mda5 morpholino injected endothelial hemogenic endothelial cell 26hpf replicate 2,8,8,NEBNext Low Input RNA Library Prep Kit,,,RNA-Seq,TRANSCRIPTOMIC,size fractionation,PAIRED,ILLUMINA,Illumina HiSeq 3000,,SRP226614,,,RNA_seq mda5 morpholino injected endothelial_hemogenic endothelial cell 26hpf replicate 2_R1.fastq.gz RNA_seq mda5 morpholino injected endothelial_hemogenic endothelial cell 26hpf replicate 2_R2.fastq.gz,fastq fastq,3238312500.0,21588750.0,RNA seq mda5 morpholino injected endothelial hemogenic endothelial cell 26hpf replicate 2 R1.fastq.gz,0:75 1:75,A:881635390;C:656958401;G:673596788;T:1025824968;N:296953,75,75,,,881635390,656958401,673596788,1025824968,296953,SRX7034714,SRS5554730,SRA983011,"Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany|Department of Cellular and Molecular Immunology","Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany",2,0.59623,0.72377,0.07781,0.08944,0.80608,0.8016,0.53277,0.53095,75,75,B,B,biological fallback assumption,illumina,hiseq_era,unknown,size_fractionation,nebnext,bulk,unknown,unknown,,Germany,2019-10-24,Pharyngula,Embryo,Endothelium,Cardiovascular System 55382,SRR10323884,SRX7034713,SRS5554730,SRP226614,PRJNA578896,Repetitive elements engage Rig I and Mda5 in interplay with Lgp2 to enhance hematopoietic stem cell emergence,PRJNA578896,Other,In this study we examine the role of RIG I like receptors RLRs in hematopoietic stem and progenitor cell formation. We have performed extensive expression analysis and chromatin accessibility assays on endothelial and hemogenic endothelial cells in knockdown animals for all the RLR receptors. Additionally we did expression analysis on animals with knockdown of two receptors. Finally we examined the upregulation of repetitive elements in hemogenic endothelial cells post treatment with valproic acid VPA or decitabine.,,,,,danRer10 raw data,,strain:AB/tu|age:not applicable|sex:pooled male and female|tissue:endothelial and hemogenic endothelial|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq mda5 morpholino injected endothelial hemogenic endothelial cell 26hpf replicate 1,7,7,NEBNext Low Input RNA Library Prep Kit,,,RNA-Seq,TRANSCRIPTOMIC,size fractionation,PAIRED,ILLUMINA,Illumina HiSeq 3000,,SRP226614,,,RNA_seq mda5 morpholino injected endothelial_hemogenic endothelial cell 26hpf replicate 1_R1.fastq.gz RNA_seq mda5 morpholino injected endothelial_hemogenic endothelial cell 26hpf replicate 1_R2.fastq.gz,fastq fastq,3255021150.0,21700141.0,RNA seq mda5 morpholino injected endothelial hemogenic endothelial cell 26hpf replicate 1 R1.fastq.gz,0:75 1:75,A:858912760;C:733048670;G:750496371;T:912263495;N:299854,75,75,,,858912760,733048670,750496371,912263495,299854,SRX7034713,SRS5554730,SRA983011,"Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany|Department of Cellular and Molecular Immunology","Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany",2,0.65481,0.71883,0.05477,0.05995,0.7903,0.7921,0.51367,0.51188,75,75,B,B,biological fallback assumption,illumina,hiseq_era,unknown,size_fractionation,nebnext,bulk,unknown,unknown,,Germany,2019-10-24,Pharyngula,Embryo,Endothelium,Cardiovascular System 55383,SRR10323885,SRX7034712,SRS5554730,SRP226614,PRJNA578896,Repetitive elements engage Rig I and Mda5 in interplay with Lgp2 to enhance hematopoietic stem cell emergence,PRJNA578896,Other,In this study we examine the role of RIG I like receptors RLRs in hematopoietic stem and progenitor cell formation. We have performed extensive expression analysis and chromatin accessibility assays on endothelial and hemogenic endothelial cells in knockdown animals for all the RLR receptors. Additionally we did expression analysis on animals with knockdown of two receptors. Finally we examined the upregulation of repetitive elements in hemogenic endothelial cells post treatment with valproic acid VPA or decitabine.,,,,,danRer10 raw data,,strain:AB/tu|age:not applicable|sex:pooled male and female|tissue:endothelial and hemogenic endothelial|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq control for mda5 morpholino injected endothelial hemogenic endothelial cell 26hpf replicate 2,6,6,NEBNext Low Input RNA Library Prep Kit,,,RNA-Seq,TRANSCRIPTOMIC,size fractionation,PAIRED,ILLUMINA,Illumina HiSeq 3000,,SRP226614,,,RNA_seq control for mda5 morpholino injected endothelial_hemogenic endothelial cell 26hpf replicate 2_R2.fastq.gz RNA_seq control for mda5 morpholino injected endothelial_hemogenic endothelial cell 26hpf replicate 2_R1.fastq.gz,fastq fastq,2413394850.0,16089299.0,RNA seq control for mda5 morpholino injected endothelial hemogenic endothelial cell 26hpf replicate 2 R1.fastq.gz,0:75 1:75,A:660807483;C:490677840;G:505039519;T:756646234;N:223774,75,75,,,660807483,490677840,505039519,756646234,223774,SRX7034712,SRS5554730,SRA983011,"Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany|Department of Cellular and Molecular Immunology","Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany",2,0.60009,0.72319,0.09185,0.10528,0.82175,0.81815,0.5234,0.51725,75,75,B,B,biological fallback assumption,illumina,hiseq_era,unknown,size_fractionation,nebnext,bulk,unknown,unknown,,Germany,2019-10-24,Pharyngula,Embryo,Endothelium,Cardiovascular System 55384,SRR10323886,SRX7034711,SRS5554730,SRP226614,PRJNA578896,Repetitive elements engage Rig I and Mda5 in interplay with Lgp2 to enhance hematopoietic stem cell emergence,PRJNA578896,Other,In this study we examine the role of RIG I like receptors RLRs in hematopoietic stem and progenitor cell formation. We have performed extensive expression analysis and chromatin accessibility assays on endothelial and hemogenic endothelial cells in knockdown animals for all the RLR receptors. Additionally we did expression analysis on animals with knockdown of two receptors. Finally we examined the upregulation of repetitive elements in hemogenic endothelial cells post treatment with valproic acid VPA or decitabine.,,,,,danRer10 raw data,,strain:AB/tu|age:not applicable|sex:pooled male and female|tissue:endothelial and hemogenic endothelial|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq control for mda5 morpholino injected endothelial hemogenic endothelial cell 26hpf replicate 1,5,5,NEBNext Low Input RNA Library Prep Kit,,,RNA-Seq,TRANSCRIPTOMIC,size fractionation,PAIRED,ILLUMINA,Illumina HiSeq 3000,,SRP226614,,,RNA_seq control for mda5 morpholino injected endothelial_hemogenic endothelial cell 26hpf replicate 1_R1.fastq.gz RNA_seq control for mda5 morpholino injected endothelial_hemogenic endothelial cell 26hpf replicate 1_R2.fastq.gz,fastq fastq,3124357200.0,20829048.0,RNA seq control for mda5 morpholino injected endothelial hemogenic endothelial cell 26hpf replicate 1 R1.fastq.gz,0:75 1:75,A:844721216;C:673572690;G:689308705;T:916479849;N:274740,75,75,,,844721216,673572690,689308705,916479849,274740,SRX7034711,SRS5554730,SRA983011,"Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany|Department of Cellular and Molecular Immunology","Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany",2,0.66396,0.73861,0.09392,0.10351,0.80856,0.80797,0.53225,0.5369,75,75,B,B,biological fallback assumption,illumina,hiseq_era,unknown,size_fractionation,nebnext,bulk,unknown,unknown,,Germany,2019-10-24,Pharyngula,Embryo,Endothelium,Cardiovascular System 55385,SRR10323891,SRX7034706,SRS5554730,SRP226614,PRJNA578896,Repetitive elements engage Rig I and Mda5 in interplay with Lgp2 to enhance hematopoietic stem cell emergence,PRJNA578896,Other,In this study we examine the role of RIG I like receptors RLRs in hematopoietic stem and progenitor cell formation. We have performed extensive expression analysis and chromatin accessibility assays on endothelial and hemogenic endothelial cells in knockdown animals for all the RLR receptors. Additionally we did expression analysis on animals with knockdown of two receptors. Finally we examined the upregulation of repetitive elements in hemogenic endothelial cells post treatment with valproic acid VPA or decitabine.,,,,,danRer10 raw data,,strain:AB/tu|age:not applicable|sex:pooled male and female|tissue:endothelial and hemogenic endothelial|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq rig 1 morpholino injected endothelial hemogenic endothelial cell 26hpf replicate 2,4,4,NEBNext Low Input RNA Library Prep Kit,,,RNA-Seq,TRANSCRIPTOMIC,size fractionation,PAIRED,ILLUMINA,Illumina HiSeq 3000,,SRP226614,,,RNA_seq rig_1 morpholino injected endothelial_hemogenic endothelial cell 26hpf replicate 2_R2.fastq.gz RNA_seq rig_1 morpholino injected endothelial_hemogenic endothelial cell 26hpf replicate 2_R1.fastq.gz,fastq fastq,2812593000.0,18750620.0,RNA seq rig 1 morpholino injected endothelial hemogenic endothelial cell 26hpf replicate 2 R1.fastq.gz,0:75 1:75,A:759189725;C:611361876;G:625876145;T:815905469;N:259785,75,75,,,759189725,611361876,625876145,815905469,259785,SRX7034706,SRS5554730,SRA983011,"Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany|Department of Cellular and Molecular Immunology","Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany",2,0.63609,0.70403,0.08285,0.0932,0.79847,0.79959,0.52487,0.52941,75,75,B,B,biological fallback assumption,illumina,hiseq_era,unknown,size_fractionation,nebnext,bulk,unknown,unknown,,Germany,2019-10-24,Pharyngula,Embryo,Endothelium,Cardiovascular System 55386,SRR10323898,SRX7034699,SRS5554730,SRP226614,PRJNA578896,Repetitive elements engage Rig I and Mda5 in interplay with Lgp2 to enhance hematopoietic stem cell emergence,PRJNA578896,Other,In this study we examine the role of RIG I like receptors RLRs in hematopoietic stem and progenitor cell formation. We have performed extensive expression analysis and chromatin accessibility assays on endothelial and hemogenic endothelial cells in knockdown animals for all the RLR receptors. Additionally we did expression analysis on animals with knockdown of two receptors. Finally we examined the upregulation of repetitive elements in hemogenic endothelial cells post treatment with valproic acid VPA or decitabine.,,,,,danRer10 raw data,,strain:AB/tu|age:not applicable|sex:pooled male and female|tissue:endothelial and hemogenic endothelial|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq decitabine treatment in hemogenic endothelial cell 26hpf replicate 2,24,24,NEBNext Low Input RNA Library Prep Kit,,,RNA-Seq,TRANSCRIPTOMIC,size fractionation,PAIRED,ILLUMINA,Illumina HiSeq 3000,,SRP226614,,,RNA_seq decitabine treatment in hemogenic endothelial cell 26hpf replicate 2_R2.fastq.gz RNA_seq decitabine treatment in hemogenic endothelial cell 26hpf replicate 2_R1.fastq.gz,fastq fastq,5849571450.0,38997143.0,RNA seq decitabine treatment in hemogenic endothelial cell 26hpf replicate 2 R1.fastq.gz,0:75 1:75,A:1574421853;C:1316832574;G:1315527058;T:1642305644;N:484321,75,75,,,1574421853,1316832574,1315527058,1642305644,484321,SRX7034699,SRS5554730,SRA983011,"Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany|Department of Cellular and Molecular Immunology","Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany",2,0.78221,0.84034,0.0684,0.07089,0.76607,0.77025,0.50712,0.50772,75,75,B,B,biological fallback assumption,illumina,hiseq_era,unknown,size_fractionation,nebnext,bulk,unknown,unknown,,Germany,2019-10-24,Pharyngula,Embryo,Endothelium,Cardiovascular System 55387,SRR10323899,SRX7034698,SRS5554730,SRP226614,PRJNA578896,Repetitive elements engage Rig I and Mda5 in interplay with Lgp2 to enhance hematopoietic stem cell emergence,PRJNA578896,Other,In this study we examine the role of RIG I like receptors RLRs in hematopoietic stem and progenitor cell formation. We have performed extensive expression analysis and chromatin accessibility assays on endothelial and hemogenic endothelial cells in knockdown animals for all the RLR receptors. Additionally we did expression analysis on animals with knockdown of two receptors. Finally we examined the upregulation of repetitive elements in hemogenic endothelial cells post treatment with valproic acid VPA or decitabine.,,,,,danRer10 raw data,,strain:AB/tu|age:not applicable|sex:pooled male and female|tissue:endothelial and hemogenic endothelial|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq decitabine treatment in hemogenic endothelial cell 26hpf replicate 1,23,23,NEBNext Low Input RNA Library Prep Kit,,,RNA-Seq,TRANSCRIPTOMIC,size fractionation,PAIRED,ILLUMINA,Illumina HiSeq 3000,,SRP226614,,,RNA_seq decitabine treatment in hemogenic endothelial cell 26hpf replicate 1_R1.fastq.gz RNA_seq decitabine treatment in hemogenic endothelial cell 26hpf replicate 1_R2.fastq.gz,fastq fastq,5656815000.0,37712100.0,RNA seq decitabine treatment in hemogenic endothelial cell 26hpf replicate 1 R1.fastq.gz,0:75 1:75,A:1487198866;C:1332723090;G:1275197163;T:1514410765;N:47285116,75,75,,,1487198866,1332723090,1275197163,1514410765,47285116,SRX7034698,SRS5554730,SRA983011,"Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany|Department of Cellular and Molecular Immunology","Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany",2,0.86399,0.76012,0.0587,0.05779,0.76461,0.9105,0.49754,0.51037,75,75,B,B,biological fallback assumption,illumina,hiseq_era,unknown,size_fractionation,nebnext,bulk,unknown,unknown,,Germany,2019-10-24,Pharyngula,Embryo,Endothelium,Cardiovascular System 55388,SRR10323900,SRX7034697,SRS5554730,SRP226614,PRJNA578896,Repetitive elements engage Rig I and Mda5 in interplay with Lgp2 to enhance hematopoietic stem cell emergence,PRJNA578896,Other,In this study we examine the role of RIG I like receptors RLRs in hematopoietic stem and progenitor cell formation. We have performed extensive expression analysis and chromatin accessibility assays on endothelial and hemogenic endothelial cells in knockdown animals for all the RLR receptors. Additionally we did expression analysis on animals with knockdown of two receptors. Finally we examined the upregulation of repetitive elements in hemogenic endothelial cells post treatment with valproic acid VPA or decitabine.,,,,,danRer10 raw data,,strain:AB/tu|age:not applicable|sex:pooled male and female|tissue:endothelial and hemogenic endothelial|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq VPA treatment in hemogenic endothelial cell 26hpf replicate 2,22,22,NEBNext Low Input RNA Library Prep Kit,,,RNA-Seq,TRANSCRIPTOMIC,size fractionation,PAIRED,ILLUMINA,Illumina HiSeq 3000,,SRP226614,,,RNA_seq VPA treatment in hemogenic endothelial cell 26hpf replicate 2_R2.fastq.gz RNA_seq VPA treatment in hemogenic endothelial cell 26hpf replicate 2_R1.fastq.gz,fastq fastq,5978780250.0,39858535.0,RNA seq VPA treatment in hemogenic endothelial cell 26hpf replicate 2 R1.fastq.gz,0:75 1:75,A:1580804547;C:1404640964;G:1399714637;T:1593586843;N:33259,75,75,,,1580804547,1404640964,1399714637,1593586843,33259,SRX7034697,SRS5554730,SRA983011,"Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany|Department of Cellular and Molecular Immunology","Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany",2,0.92216,0.92477,0.04155,0.04126,0.74537,0.7512,0.48148,0.49049,75,75,B,B,biological fallback assumption,illumina,hiseq_era,unknown,size_fractionation,nebnext,bulk,unknown,unknown,,Germany,2019-10-24,Pharyngula,Embryo,Endothelium,Cardiovascular System 55389,SRR10323901,SRX7034696,SRS5554730,SRP226614,PRJNA578896,Repetitive elements engage Rig I and Mda5 in interplay with Lgp2 to enhance hematopoietic stem cell emergence,PRJNA578896,Other,In this study we examine the role of RIG I like receptors RLRs in hematopoietic stem and progenitor cell formation. We have performed extensive expression analysis and chromatin accessibility assays on endothelial and hemogenic endothelial cells in knockdown animals for all the RLR receptors. Additionally we did expression analysis on animals with knockdown of two receptors. Finally we examined the upregulation of repetitive elements in hemogenic endothelial cells post treatment with valproic acid VPA or decitabine.,,,,,danRer10 raw data,,strain:AB/tu|age:not applicable|sex:pooled male and female|tissue:endothelial and hemogenic endothelial|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq VPA or decitabine treatment in hemogenic endothelial cell 26hpf replicate 1,21,21,NEBNext Low Input RNA Library Prep Kit,,,RNA-Seq,TRANSCRIPTOMIC,size fractionation,PAIRED,ILLUMINA,Illumina HiSeq 3000,,SRP226614,,,RNA_seq VPA treatment in hemogenic endothelial cell 26hpf replicate 1_R1.fastq.gz RNA_seq VPA treatment in hemogenic endothelial cell 26hpf replicate 1_R2.fastq.gz,fastq fastq,8777730900.0,58518206.0,RNA seq VPA treatment in hemogenic endothelial cell 26hpf replicate 1 R1.fastq.gz,0:75 1:75,A:2331650285;C:2053244561;G:2042022053;T:2350762388;N:51613,75,75,,,2331650285,2053244561,2042022053,2350762388,51613,SRX7034696,SRS5554730,SRA983011,"Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany|Department of Cellular and Molecular Immunology","Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany",2,0.92143,0.92455,0.04604,0.04567,0.73361,0.73923,0.4802,0.48613,75,75,B,B,biological fallback assumption,illumina,hiseq_era,unknown,size_fractionation,nebnext,bulk,unknown,unknown,,Germany,2019-10-24,Pharyngula,Embryo,Endothelium,Cardiovascular System 55390,SRR10323902,SRX7034695,SRS5554730,SRP226614,PRJNA578896,Repetitive elements engage Rig I and Mda5 in interplay with Lgp2 to enhance hematopoietic stem cell emergence,PRJNA578896,Other,In this study we examine the role of RIG I like receptors RLRs in hematopoietic stem and progenitor cell formation. We have performed extensive expression analysis and chromatin accessibility assays on endothelial and hemogenic endothelial cells in knockdown animals for all the RLR receptors. Additionally we did expression analysis on animals with knockdown of two receptors. Finally we examined the upregulation of repetitive elements in hemogenic endothelial cells post treatment with valproic acid VPA or decitabine.,,,,,danRer10 raw data,,strain:AB/tu|age:not applicable|sex:pooled male and female|tissue:endothelial and hemogenic endothelial|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq rig 1 morpholino injected endothelial hemogenic endothelial cell 26hpf replicate 1,3,3,NEBNext Low Input RNA Library Prep Kit,,,RNA-Seq,TRANSCRIPTOMIC,size fractionation,PAIRED,ILLUMINA,Illumina HiSeq 3000,,SRP226614,,,RNA_seq rig_1 morpholino injected endothelial_hemogenic endothelial cell 26hpf replicate 1_R1.fastq.gz RNA_seq rig_1 morpholino injected endothelial_hemogenic endothelial cell 26hpf replicate 1_R2.fastq.gz,fastq fastq,3613041150.0,24086941.0,RNA seq rig 1 morpholino injected endothelial hemogenic endothelial cell 26hpf replicate 1 R1.fastq.gz,0:75 1:75,A:972417798;C:795483066;G:808300399;T:1036510724;N:329163,75,75,,,972417798,795483066,808300399,1036510724,329163,SRX7034695,SRS5554730,SRA983011,"Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany|Department of Cellular and Molecular Immunology","Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany",2,0.66853,0.7231,0.08329,0.0907,0.78953,0.79131,0.51481,0.52637,75,75,B,B,biological fallback assumption,illumina,hiseq_era,unknown,size_fractionation,nebnext,bulk,unknown,unknown,,Germany,2019-10-24,Pharyngula,Embryo,Endothelium,Cardiovascular System 55391,SRR10323903,SRX7034694,SRS5554730,SRP226614,PRJNA578896,Repetitive elements engage Rig I and Mda5 in interplay with Lgp2 to enhance hematopoietic stem cell emergence,PRJNA578896,Other,In this study we examine the role of RIG I like receptors RLRs in hematopoietic stem and progenitor cell formation. We have performed extensive expression analysis and chromatin accessibility assays on endothelial and hemogenic endothelial cells in knockdown animals for all the RLR receptors. Additionally we did expression analysis on animals with knockdown of two receptors. Finally we examined the upregulation of repetitive elements in hemogenic endothelial cells post treatment with valproic acid VPA or decitabine.,,,,,danRer10 raw data,,strain:AB/tu|age:not applicable|sex:pooled male and female|tissue:endothelial and hemogenic endothelial|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq control for VPA or decitabine treatment in hemogenic endothelial cell 26hpf replicate 2,20,20,NEBNext Low Input RNA Library Prep Kit,,,RNA-Seq,TRANSCRIPTOMIC,size fractionation,PAIRED,ILLUMINA,Illumina HiSeq 3000,,SRP226614,,,RNA_seq control for VPA_or_decitabine treatment in hemogenic endothelial cell 26hpf replicate 2_R1.fastq.gz RNA_seq control for VPA_or_decitabine treatment in hemogenic endothelial cell 26hpf replicate 2_R2.fastq.gz,fastq fastq,7211828100.0,48078854.0,RNA seq control for VPA or decitabine treatment in hemogenic endothelial cell 26hpf replicate 2 R1.fastq.gz,0:75 1:75,A:1904350731;C:1693709371;G:1687946675;T:1925778331;N:42992,75,75,,,1904350731,1693709371,1687946675,1925778331,42992,SRX7034694,SRS5554730,SRA983011,"Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany|Department of Cellular and Molecular Immunology","Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany",2,0.91819,0.92224,0.03958,0.03841,0.75584,0.76161,0.46923,0.46415,75,75,B,B,biological fallback assumption,illumina,hiseq_era,unknown,size_fractionation,nebnext,bulk,unknown,unknown,,Germany,2019-10-24,Pharyngula,Embryo,Endothelium,Cardiovascular System 55392,SRR10323904,SRX7034693,SRS5554730,SRP226614,PRJNA578896,Repetitive elements engage Rig I and Mda5 in interplay with Lgp2 to enhance hematopoietic stem cell emergence,PRJNA578896,Other,In this study we examine the role of RIG I like receptors RLRs in hematopoietic stem and progenitor cell formation. We have performed extensive expression analysis and chromatin accessibility assays on endothelial and hemogenic endothelial cells in knockdown animals for all the RLR receptors. Additionally we did expression analysis on animals with knockdown of two receptors. Finally we examined the upregulation of repetitive elements in hemogenic endothelial cells post treatment with valproic acid VPA or decitabine.,,,,,danRer10 raw data,,strain:AB/tu|age:not applicable|sex:pooled male and female|tissue:endothelial and hemogenic endothelial|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq control for VPA treatment in hemogenic endothelial cell 26hpf replicate 1,19,19,NEBNext Low Input RNA Library Prep Kit,,,RNA-Seq,TRANSCRIPTOMIC,size fractionation,PAIRED,ILLUMINA,Illumina HiSeq 3000,,SRP226614,,,RNA_seq control for VPA_or_decitabine treatment in hemogenic endothelial cell 26hpf replicate 1_R1.fastq.gz RNA_seq control for VPA_or_decitabine treatment in hemogenic endothelial cell 26hpf replicate 1_R2.fastq.gz,fastq fastq,8021297850.0,53475319.0,RNA seq control for VPA or decitabine treatment in hemogenic endothelial cell 26hpf replicate 1 R1.fastq.gz,0:75 1:75,A:2121666298;C:1880005094;G:1872358379;T:2147221627;N:46452,75,75,,,2121666298,1880005094,1872358379,2147221627,46452,SRX7034693,SRS5554730,SRA983011,"Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany|Department of Cellular and Molecular Immunology","Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany",2,0.91273,0.91897,0.0437,0.04345,0.75485,0.76037,0.46259,0.47199,75,75,B,B,biological fallback assumption,illumina,hiseq_era,unknown,size_fractionation,nebnext,bulk,unknown,unknown,,Germany,2019-10-24,Pharyngula,Embryo,Endothelium,Cardiovascular System 55393,SRR10323905,SRX7034692,SRS5554730,SRP226614,PRJNA578896,Repetitive elements engage Rig I and Mda5 in interplay with Lgp2 to enhance hematopoietic stem cell emergence,PRJNA578896,Other,In this study we examine the role of RIG I like receptors RLRs in hematopoietic stem and progenitor cell formation. We have performed extensive expression analysis and chromatin accessibility assays on endothelial and hemogenic endothelial cells in knockdown animals for all the RLR receptors. Additionally we did expression analysis on animals with knockdown of two receptors. Finally we examined the upregulation of repetitive elements in hemogenic endothelial cells post treatment with valproic acid VPA or decitabine.,,,,,danRer10 raw data,,strain:AB/tu|age:not applicable|sex:pooled male and female|tissue:endothelial and hemogenic endothelial|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq mda5 lgp2 morpholino injected endothelial hemogenic endothelial cell 26hpf replicate 2,18,18,TruSeq stranded mRNA,,,RNA-Seq,TRANSCRIPTOMIC,size fractionation,PAIRED,ILLUMINA,Illumina HiSeq 3000,,SRP226614,,,RNA_seq mda5_lgp2 morpholino injected endothelial_hemogenic endothelial cell 26hpf replicate 2_R1.fastq.gz RNA_seq mda5_lgp2 morpholino injected endothelial_hemogenic endothelial cell 26hpf replicate 2_R2.fastq.gz,fastq fastq,4925792850.0,32838619.0,RNA seq mda5 lgp2 morpholino injected endothelial hemogenic endothelial cell 26hpf replicate 2 R1.fastq.gz,0:75 1:75,A:1327496924;C:1143172265;G:1121827107;T:1332765205;N:531349,75,75,,,1327496924,1143172265,1121827107,1332765205,531349,SRX7034692,SRS5554730,SRA983011,"Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany|Department of Cellular and Molecular Immunology","Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany",2,0.9235,0.923,0.07189,0.07157,0.74576,0.7486,0.46424,0.46997,75,75,B,B,biological fallback assumption,illumina,hiseq_era,unknown,size_fractionation,trueseq,bulk,unknown,unknown,,Germany,2019-10-24,Pharyngula,Embryo,Endothelium,Cardiovascular System 55394,SRR10323906,SRX7034691,SRS5554730,SRP226614,PRJNA578896,Repetitive elements engage Rig I and Mda5 in interplay with Lgp2 to enhance hematopoietic stem cell emergence,PRJNA578896,Other,In this study we examine the role of RIG I like receptors RLRs in hematopoietic stem and progenitor cell formation. We have performed extensive expression analysis and chromatin accessibility assays on endothelial and hemogenic endothelial cells in knockdown animals for all the RLR receptors. Additionally we did expression analysis on animals with knockdown of two receptors. Finally we examined the upregulation of repetitive elements in hemogenic endothelial cells post treatment with valproic acid VPA or decitabine.,,,,,danRer10 raw data,,strain:AB/tu|age:not applicable|sex:pooled male and female|tissue:endothelial and hemogenic endothelial|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq mda5 lgp2 morpholino injected endothelial hemogenic endothelial cell 26hpf replicate 1,17,17,TruSeq stranded mRNA,,,RNA-Seq,TRANSCRIPTOMIC,size fractionation,PAIRED,ILLUMINA,Illumina HiSeq 3000,,SRP226614,,,RNA_seq mda5_lgp2 morpholino injected endothelial_hemogenic endothelial cell 26hpf replicate 1_R1.fastq.gz RNA_seq mda5_lgp2 morpholino injected endothelial_hemogenic endothelial cell 26hpf replicate 1_R2.fastq.gz,fastq fastq,4481194200.0,29874628.0,RNA seq mda5 lgp2 morpholino injected endothelial hemogenic endothelial cell 26hpf replicate 1 R1.fastq.gz,0:75 1:75,A:1207561849;C:1040055195;G:1022613796;T:1210492037;N:471323,75,75,,,1207561849,1040055195,1022613796,1210492037,471323,SRX7034691,SRS5554730,SRA983011,"Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany|Department of Cellular and Molecular Immunology","Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany",2,0.92094,0.92157,0.07292,0.07281,0.74704,0.75067,0.47205,0.47416,75,75,B,B,biological fallback assumption,illumina,hiseq_era,unknown,size_fractionation,trueseq,bulk,unknown,unknown,,Germany,2019-10-24,Pharyngula,Embryo,Endothelium,Cardiovascular System 55395,SRR10323907,SRX7034690,SRS5554730,SRP226614,PRJNA578896,Repetitive elements engage Rig I and Mda5 in interplay with Lgp2 to enhance hematopoietic stem cell emergence,PRJNA578896,Other,In this study we examine the role of RIG I like receptors RLRs in hematopoietic stem and progenitor cell formation. We have performed extensive expression analysis and chromatin accessibility assays on endothelial and hemogenic endothelial cells in knockdown animals for all the RLR receptors. Additionally we did expression analysis on animals with knockdown of two receptors. Finally we examined the upregulation of repetitive elements in hemogenic endothelial cells post treatment with valproic acid VPA or decitabine.,,,,,danRer10 raw data,,strain:AB/tu|age:not applicable|sex:pooled male and female|tissue:endothelial and hemogenic endothelial|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq rig 1 lgp2 morpholino injected endothelial hemogenic endothelial cell 26hpf replicate 2,16,16,TruSeq stranded mRNA,,,RNA-Seq,TRANSCRIPTOMIC,size fractionation,PAIRED,ILLUMINA,Illumina HiSeq 3000,,SRP226614,,,RNA_seq rig_1_lgp2 morpholino injected endothelial_hemogenic endothelial cell 26hpf replicate 2_R2.fastq.gz RNA_seq rig_1_lgp2 morpholino injected endothelial_hemogenic endothelial cell 26hpf replicate 2_R1.fastq.gz,fastq fastq,2071385250.0,13809235.0,RNA seq rig 1 lgp2 morpholino injected endothelial hemogenic endothelial cell 26hpf replicate 2 R1.fastq.gz,0:75 1:75,A:497024628;C:535934066;G:538798491;T:499539772;N:88293,75,75,,,497024628,535934066,538798491,499539772,88293,SRX7034690,SRS5554730,SRA983011,"Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany|Department of Cellular and Molecular Immunology","Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany",2,0.92507,0.92563,0.0745,0.07106,0.74148,0.74186,0.5137,0.52923,75,75,B,B,biological fallback assumption,illumina,hiseq_era,unknown,size_fractionation,trueseq,bulk,unknown,unknown,,Germany,2019-10-24,Pharyngula,Embryo,Endothelium,Cardiovascular System 55396,SRR10323908,SRX7034689,SRS5554730,SRP226614,PRJNA578896,Repetitive elements engage Rig I and Mda5 in interplay with Lgp2 to enhance hematopoietic stem cell emergence,PRJNA578896,Other,In this study we examine the role of RIG I like receptors RLRs in hematopoietic stem and progenitor cell formation. We have performed extensive expression analysis and chromatin accessibility assays on endothelial and hemogenic endothelial cells in knockdown animals for all the RLR receptors. Additionally we did expression analysis on animals with knockdown of two receptors. Finally we examined the upregulation of repetitive elements in hemogenic endothelial cells post treatment with valproic acid VPA or decitabine.,,,,,danRer10 raw data,,strain:AB/tu|age:not applicable|sex:pooled male and female|tissue:endothelial and hemogenic endothelial|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq rig 1 lgp2 morpholino injected endothelial hemogenic endothelial cell 26hpf replicate 1,15,15,TruSeq stranded mRNA,,,RNA-Seq,TRANSCRIPTOMIC,size fractionation,PAIRED,ILLUMINA,Illumina HiSeq 3000,,SRP226614,,,RNA_seq rig_1_lgp2 morpholino injected endothelial_hemogenic endothelial cell 26hpf replicate 1_R1.fastq.gz RNA_seq rig_1_lgp2 morpholino injected endothelial_hemogenic endothelial cell 26hpf replicate 1_R2.fastq.gz,fastq fastq,1708336800.0,11388912.0,RNA seq rig 1 lgp2 morpholino injected endothelial hemogenic endothelial cell 26hpf replicate 1 R1.fastq.gz,0:75 1:75,A:413739883;C:438115098;G:440441368;T:415968029;N:72422,75,75,,,413739883,438115098,440441368,415968029,72422,SRX7034689,SRS5554730,SRA983011,"Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany|Department of Cellular and Molecular Immunology","Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany",2,0.92948,0.93123,0.08112,0.07757,0.7472,0.74921,0.49384,0.502,75,75,B,B,biological fallback assumption,illumina,hiseq_era,unknown,size_fractionation,trueseq,bulk,unknown,unknown,,Germany,2019-10-24,Pharyngula,Embryo,Endothelium,Cardiovascular System 55397,SRR10323909,SRX7034688,SRS5554730,SRP226614,PRJNA578896,Repetitive elements engage Rig I and Mda5 in interplay with Lgp2 to enhance hematopoietic stem cell emergence,PRJNA578896,Other,In this study we examine the role of RIG I like receptors RLRs in hematopoietic stem and progenitor cell formation. We have performed extensive expression analysis and chromatin accessibility assays on endothelial and hemogenic endothelial cells in knockdown animals for all the RLR receptors. Additionally we did expression analysis on animals with knockdown of two receptors. Finally we examined the upregulation of repetitive elements in hemogenic endothelial cells post treatment with valproic acid VPA or decitabine.,,,,,danRer10 raw data,,strain:AB/tu|age:not applicable|sex:pooled male and female|tissue:endothelial and hemogenic endothelial|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq control for double morphants endothelial hemogenic endothelial cell 26hpf replicate 2,14,14,TruSeq stranded mRNA,,,RNA-Seq,TRANSCRIPTOMIC,size fractionation,PAIRED,ILLUMINA,Illumina HiSeq 3000,,SRP226614,,,RNA_seq control for double morphants endothelial_hemogenic endothelial cell 26hpf replicate 2_R1.fastq.gz RNA_seq control for double morphants endothelial_hemogenic endothelial cell 26hpf replicate 2_R2.fastq.gz,fastq fastq,2742841800.0,18285612.0,RNA seq control for double morphants endothelial hemogenic endothelial cell 26hpf replicate 2 R1.fastq.gz,0:75 1:75,A:771268784;C:600759252;G:605972112;T:764554978;N:286674,75,75,,,771268784,600759252,605972112,764554978,286674,SRX7034688,SRS5554730,SRA983011,"Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany|Department of Cellular and Molecular Immunology","Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany",2,0.91195,0.91276,0.15552,0.15531,0.7191,0.7247,0.487,0.47379,75,75,B,B,biological fallback assumption,illumina,hiseq_era,unknown,size_fractionation,trueseq,bulk,unknown,unknown,,Germany,2019-10-24,Pharyngula,Embryo,Endothelium,Cardiovascular System 55398,SRR10323910,SRX7034687,SRS5554730,SRP226614,PRJNA578896,Repetitive elements engage Rig I and Mda5 in interplay with Lgp2 to enhance hematopoietic stem cell emergence,PRJNA578896,Other,In this study we examine the role of RIG I like receptors RLRs in hematopoietic stem and progenitor cell formation. We have performed extensive expression analysis and chromatin accessibility assays on endothelial and hemogenic endothelial cells in knockdown animals for all the RLR receptors. Additionally we did expression analysis on animals with knockdown of two receptors. Finally we examined the upregulation of repetitive elements in hemogenic endothelial cells post treatment with valproic acid VPA or decitabine.,,,,,danRer10 raw data,,strain:AB/tu|age:not applicable|sex:pooled male and female|tissue:endothelial and hemogenic endothelial|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq control for double morphants endothelial hemogenic endothelial cell 26hpf replicate 1,13,13,TruSeq stranded mRNA,,,RNA-Seq,TRANSCRIPTOMIC,size fractionation,PAIRED,ILLUMINA,Illumina HiSeq 3000,,SRP226614,,,RNA_seq control for double morphants endothelial_hemogenic endothelial cell 26hpf replicate 1_R1.fastq.gz RNA_seq control for double morphants endothelial_hemogenic endothelial cell 26hpf replicate 1_R2.fastq.gz,fastq fastq,1909021350.0,12726809.0,RNA seq control for double morphants endothelial hemogenic endothelial cell 26hpf replicate 1 R1.fastq.gz,0:75 1:75,A:536542827;C:420010389;G:423642042;T:528630203;N:195889,75,75,,,536542827,420010389,423642042,528630203,195889,SRX7034687,SRS5554730,SRA983011,"Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany|Department of Cellular and Molecular Immunology","Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany",2,0.91535,0.91534,0.11578,0.11457,0.73705,0.74373,0.47609,0.47115,75,75,B,B,biological fallback assumption,illumina,hiseq_era,unknown,size_fractionation,trueseq,bulk,unknown,unknown,,Germany,2019-10-24,Pharyngula,Embryo,Endothelium,Cardiovascular System 55399,SRR10323911,SRX7034686,SRS5554730,SRP226614,PRJNA578896,Repetitive elements engage Rig I and Mda5 in interplay with Lgp2 to enhance hematopoietic stem cell emergence,PRJNA578896,Other,In this study we examine the role of RIG I like receptors RLRs in hematopoietic stem and progenitor cell formation. We have performed extensive expression analysis and chromatin accessibility assays on endothelial and hemogenic endothelial cells in knockdown animals for all the RLR receptors. Additionally we did expression analysis on animals with knockdown of two receptors. Finally we examined the upregulation of repetitive elements in hemogenic endothelial cells post treatment with valproic acid VPA or decitabine.,,,,,danRer10 raw data,,strain:AB/tu|age:not applicable|sex:pooled male and female|tissue:endothelial and hemogenic endothelial|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq lgp2 morpholino injected endothelial hemogenic endothelial cell 26hpf replicate 2,12,12,NEBNext Low Input RNA Library Prep Kit,,,RNA-Seq,TRANSCRIPTOMIC,size fractionation,PAIRED,ILLUMINA,Illumina HiSeq 3000,,SRP226614,,,RNA_seq lgp2 morpholino injected endothelial_hemogenic endothelial cell 26hpf replicate 2_R1.fastq.gz RNA_seq lgp2 morpholino injected endothelial_hemogenic endothelial cell 26hpf replicate 2_R2.fastq.gz,fastq fastq,5135290500.0,34235270.0,RNA seq lgp2 morpholino injected endothelial hemogenic endothelial cell 26hpf replicate 2 R1.fastq.gz,0:75 1:75,A:1339180940;C:1202946694;G:1230552771;T:1362120185;N:489910,75,75,,,1339180940,1202946694,1230552771,1362120185,489910,SRX7034686,SRS5554730,SRA983011,"Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany|Department of Cellular and Molecular Immunology","Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany",2,0.66031,0.70687,0.04575,0.04896,0.81075,0.81195,0.50951,0.47552,75,75,B,B,biological fallback assumption,illumina,hiseq_era,unknown,size_fractionation,nebnext,bulk,unknown,unknown,,Germany,2019-10-24,Pharyngula,Embryo,Endothelium,Cardiovascular System 55400,SRR10323912,SRX7034685,SRS5554730,SRP226614,PRJNA578896,Repetitive elements engage Rig I and Mda5 in interplay with Lgp2 to enhance hematopoietic stem cell emergence,PRJNA578896,Other,In this study we examine the role of RIG I like receptors RLRs in hematopoietic stem and progenitor cell formation. We have performed extensive expression analysis and chromatin accessibility assays on endothelial and hemogenic endothelial cells in knockdown animals for all the RLR receptors. Additionally we did expression analysis on animals with knockdown of two receptors. Finally we examined the upregulation of repetitive elements in hemogenic endothelial cells post treatment with valproic acid VPA or decitabine.,,,,,danRer10 raw data,,strain:AB/tu|age:not applicable|sex:pooled male and female|tissue:endothelial and hemogenic endothelial|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq lgp2 morpholino injected endothelial hemogenic endothelial cell 26hpf replicate 1,11,11,NEBNext Low Input RNA Library Prep Kit,,,RNA-Seq,TRANSCRIPTOMIC,size fractionation,PAIRED,ILLUMINA,Illumina HiSeq 3000,,SRP226614,,,RNA_seq lgp2 morpholino injected endothelial_hemogenic endothelial cell 26hpf replicate 1_R1.fastq.gz RNA_seq lgp2 morpholino injected endothelial_hemogenic endothelial cell 26hpf replicate 1_R2.fastq.gz,fastq fastq,3890046300.0,25933642.0,RNA seq lgp2 morpholino injected endothelial hemogenic endothelial cell 26hpf replicate 1 R1.fastq.gz,0:75 1:75,A:1020376762;C:903218301;G:916043426;T:1050047618;N:360193,75,75,,,1020376762,903218301,916043426,1050047618,360193,SRX7034685,SRS5554730,SRA983011,"Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany|Department of Cellular and Molecular Immunology","Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany",2,0.70733,0.75223,0.05929,0.06271,0.80807,0.81071,0.48475,0.49323,75,75,B,B,biological fallback assumption,illumina,hiseq_era,unknown,size_fractionation,nebnext,bulk,unknown,unknown,,Germany,2019-10-24,Pharyngula,Embryo,Endothelium,Cardiovascular System 55401,SRR10323913,SRX7034684,SRS5554730,SRP226614,PRJNA578896,Repetitive elements engage Rig I and Mda5 in interplay with Lgp2 to enhance hematopoietic stem cell emergence,PRJNA578896,Other,In this study we examine the role of RIG I like receptors RLRs in hematopoietic stem and progenitor cell formation. We have performed extensive expression analysis and chromatin accessibility assays on endothelial and hemogenic endothelial cells in knockdown animals for all the RLR receptors. Additionally we did expression analysis on animals with knockdown of two receptors. Finally we examined the upregulation of repetitive elements in hemogenic endothelial cells post treatment with valproic acid VPA or decitabine.,,,,,danRer10 raw data,,strain:AB/tu|age:not applicable|sex:pooled male and female|tissue:endothelial and hemogenic endothelial|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq control for rig 1 morpholino injected endothelial hemogenic endothelial cell 26hpf replicate 2,2,2,NEBNext Low Input RNA Library Prep Kit,,,RNA-Seq,TRANSCRIPTOMIC,size fractionation,PAIRED,ILLUMINA,Illumina HiSeq 3000,,SRP226614,,,RNA_seq control for rig_1 morpholino injected endothelial_hemogenic endothelial cell 26hpf replicate 2_R1.fastq.gz RNA_seq control for rig_1 morpholino injected endothelial_hemogenic endothelial cell 26hpf replicate 2_R2.fastq.gz,fastq fastq,2547796350.0,16985309.0,RNA seq control for rig 1 morpholino injected endothelial hemogenic endothelial cell 26hpf replicate 2 R1.fastq.gz,0:75 1:75,A:686259539;C:560800822;G:567842650;T:732652800;N:240539,75,75,,,686259539,560800822,567842650,732652800,240539,SRX7034684,SRS5554730,SRA983011,"Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany|Department of Cellular and Molecular Immunology","Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany",2,0.70188,0.75886,0.08072,0.08833,0.8034,0.80649,0.51507,0.5194,75,75,B,B,biological fallback assumption,illumina,hiseq_era,unknown,size_fractionation,nebnext,bulk,unknown,unknown,,Germany,2019-10-24,Pharyngula,Embryo,Endothelium,Cardiovascular System 55402,SRR10323914,SRX7034683,SRS5554730,SRP226614,PRJNA578896,Repetitive elements engage Rig I and Mda5 in interplay with Lgp2 to enhance hematopoietic stem cell emergence,PRJNA578896,Other,In this study we examine the role of RIG I like receptors RLRs in hematopoietic stem and progenitor cell formation. We have performed extensive expression analysis and chromatin accessibility assays on endothelial and hemogenic endothelial cells in knockdown animals for all the RLR receptors. Additionally we did expression analysis on animals with knockdown of two receptors. Finally we examined the upregulation of repetitive elements in hemogenic endothelial cells post treatment with valproic acid VPA or decitabine.,,,,,danRer10 raw data,,strain:AB/tu|age:not applicable|sex:pooled male and female|tissue:endothelial and hemogenic endothelial|BioSampleModel:Model organism or animal,,,,,,,,,RNA seq control for rig 1 morpholino injected endothelial hemogenic endothelial cell 26hpf replicate 1,1,1,NEBNext Low Input RNA Library Prep Kit,,,RNA-Seq,TRANSCRIPTOMIC,size fractionation,PAIRED,ILLUMINA,Illumina HiSeq 3000,,SRP226614,,,RNA_seq control for rig_1 morpholino injected endothelial_hemogenic endothelial cell 26hpf replicate 1_R1.fastq.gz RNA_seq control for rig_1 morpholino injected endothelial_hemogenic endothelial cell 26hpf replicate 1_R2.fastq.gz,fastq fastq,2438070600.0,16253804.0,RNA seq control for rig 1 morpholino injected endothelial hemogenic endothelial cell 26hpf replicate 1 R1.fastq.gz,0:75 1:75,A:654282012;C:534555119;G:543878428;T:705130425;N:224616,75,75,,,654282012,534555119,543878428,705130425,224616,SRX7034683,SRS5554730,SRA983011,"Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany|Department of Cellular and Molecular Immunology","Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany",2,0.69336,0.75626,0.09168,0.09896,0.80166,0.80253,0.51795,0.52538,75,75,B,B,biological fallback assumption,illumina,hiseq_era,unknown,size_fractionation,nebnext,bulk,unknown,unknown,,Germany,2019-10-24,Pharyngula,Embryo,Endothelium,Cardiovascular System